JP7138639B2 - 組成物 - Google Patents

組成物 Download PDF

Info

Publication number
JP7138639B2
JP7138639B2 JP2019533040A JP2019533040A JP7138639B2 JP 7138639 B2 JP7138639 B2 JP 7138639B2 JP 2019533040 A JP2019533040 A JP 2019533040A JP 2019533040 A JP2019533040 A JP 2019533040A JP 7138639 B2 JP7138639 B2 JP 7138639B2
Authority
JP
Japan
Prior art keywords
extract
composition
inflammation
rubus idaeus
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019533040A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020515511A5 (enExample
JP2020515511A (ja
Inventor
ルクゼネー，ローマン
エリザベス レニー フォンカ－ベルソン，パスカル
ドゥニーズ ファルカオ，レイラ
テノン，マシュー
チャール ビリー，アントニー
ローラー，マーク
フュレー，ニコラ
バーティク，シモナ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan France Naturals SAS
Original Assignee
Naturex SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naturex SA filed Critical Naturex SA
Publication of JP2020515511A publication Critical patent/JP2020515511A/ja
Publication of JP2020515511A5 publication Critical patent/JP2020515511A5/ja
Application granted granted Critical
Publication of JP7138639B2 publication Critical patent/JP7138639B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Food Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
JP2019533040A 2016-12-23 2017-12-21 組成物 Active JP7138639B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1622161.6 2016-12-23
GB1622161.6A GB2558275A (en) 2016-12-23 2016-12-23 Compositions
PCT/EP2017/084266 WO2018115381A1 (en) 2016-12-23 2017-12-21 Compositions

Publications (3)

Publication Number Publication Date
JP2020515511A JP2020515511A (ja) 2020-05-28
JP2020515511A5 JP2020515511A5 (enExample) 2021-01-14
JP7138639B2 true JP7138639B2 (ja) 2022-09-16

Family

ID=58360662

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019533040A Active JP7138639B2 (ja) 2016-12-23 2017-12-21 組成物

Country Status (7)

Country Link
US (2) US11219657B2 (enExample)
EP (1) EP3558334B1 (enExample)
JP (1) JP7138639B2 (enExample)
KR (1) KR102521352B1 (enExample)
CN (1) CN110139658B (enExample)
GB (1) GB2558275A (enExample)
WO (1) WO2018115381A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2558275A (en) * 2016-12-23 2018-07-11 Naturex Sa Compositions
KR102148602B1 (ko) * 2019-03-29 2020-08-26 연세대학교 산학협력단 통풍 및 가성통풍 진단 키트 및 이를 진단하기 위한 정보 제공 방법
JP6988016B1 (ja) * 2021-04-22 2022-01-05 佐藤製薬株式会社 グランザイムｂ抑制剤
NL2036772B1 (en) * 2024-01-10 2025-07-22 Univ Guizhou Medical Method for preparing anti-inflammatory extract of miao ethnomedicine rubus multibracteatus

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001163794A (ja) 1999-12-03 2001-06-19 Shiseido Co Ltd ヒアルロン酸産生促進剤および皮膚外用剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
KR20010067023A (ko) * 2000-12-13 2001-07-12 류희영 골다공증, 관절통, 관절염 치료제 및 그 제조 방법
KR100444599B1 (ko) * 2001-08-17 2004-08-16 주식회사 태평양 피부자극 및 염증완화 효과를 갖는 라스베리 잎 또는 열매추출물을 함유한 피부 외용제 조성물
WO2003074067A1 (en) 2002-03-01 2003-09-12 Stoner Gary D Compositions of and derived from strawberry and raspberry and therapeutic uses therefor
US7709031B2 (en) * 2003-05-28 2010-05-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Angiogenic agents from plant extracts, gallic acid, and derivatives
JP5328560B2 (ja) * 2008-10-21 2013-10-30 キヤノン株式会社 インクジェット記録ヘッドおよびインクジェット記録方法
WO2012103637A1 (en) * 2011-02-02 2012-08-09 Justbio Inc. Functional foods and beverages with synergistic properties to promote homeostasis
KR101287021B1 (ko) * 2012-12-31 2013-07-17 주식회사 제닉 초음파 추출법을 이용한 항산화, 항염증 및 아토피 피부 개선용 화장료 조성물 및 이의 제조 방법
CN104288428A (zh) * 2014-09-22 2015-01-21 彭阳 一种治疗类风湿性关节炎的中药组合物
CN104306517A (zh) * 2014-10-24 2015-01-28 王栋 一种治疗风湿性关节炎的药剂
CN104288467A (zh) * 2014-11-03 2015-01-21 李�荣 一种护理科治疗类风湿性关节炎的药物组合物
US10543242B2 (en) * 2014-12-11 2020-01-28 Felician Stancioiu Composition for the treatment of joint conditions
CN104829737B (zh) * 2015-04-30 2017-09-29 华南理工大学 一种覆盆子叶粗多糖及其制备方法与应用
GB2558275A (en) * 2016-12-23 2018-07-11 Naturex Sa Compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001163794A (ja) 1999-12-03 2001-06-19 Shiseido Co Ltd ヒアルロン酸産生促進剤および皮膚外用剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RUSSELL VICKERS E; ET AL，RASPBERRY LEAF HERBAL EXTRACT SIGNIFICANTLY REDUCES PAIN AND INFLAMMATION IN ORAL 以下備考，OPEN JOURNAL OF DENTISTRY AND ORAL MEDICINE，2015年08月，VOL:3, NR:3，PAGE(S):73 - 81，http://www.hrpub.org/download/20150930/OJDOM3-18004723.pdf，LICHEN PLANUS PATIENTS - A CASE SERIES ANALYSIS

Also Published As

Publication number Publication date
GB201622161D0 (en) 2017-02-08
EP3558334A1 (en) 2019-10-30
KR20190100262A (ko) 2019-08-28
CN110139658B (zh) 2022-06-14
CN110139658A (zh) 2019-08-16
WO2018115381A1 (en) 2018-06-28
US20200222486A1 (en) 2020-07-16
KR102521352B1 (ko) 2023-04-12
US20220088107A1 (en) 2022-03-24
US11219657B2 (en) 2022-01-11
GB2558275A (en) 2018-07-11
EP3558334B1 (en) 2025-08-27
JP2020515511A (ja) 2020-05-28

Similar Documents

Publication Publication Date Title
US20220088107A1 (en) Method for treating or preventing inflammation
Zhang et al. Puerarin prevents LPS-induced osteoclast formation and bone loss via inhibition of Akt activation
Han et al. Effect of honey bee venom on microglial cells nitric oxide and tumor necrosis factor-α production stimulated by LPS
AU2014292541B2 (en) Alkaloid compositions from ribes species to treat conditions assosiated with mitochondrial function or inhibition of PDE4, PDE5 and IKK-Beta
WO2002003996A1 (en) Use of dammarane-type tritepenoid saporins
CN1289079C (zh) 仙人掌提取物和由其分离的化合物在制备保护神经细胞的药物中的应用
WO2015176539A1 (zh) 异喹啉生物碱衍生物用于制备促进ampk活性的药物的用途
EP2139504A1 (en) Standardized bioactive herbal extracts
EP3979817A1 (en) Composition for prostaglandin transporter inhibition and related therapeutic applications
HK40012494A (en) Use of an extract obtained from the stems and/or the leaves of rubus idaeus
HK40012494B (en) Use of an extract obtained from the stems and/or the leaves of rubus idaeus
KR102429980B1 (ko) 풀무치 추출물을 함유하는 신경염증 질환의 예방 또는 치료용 조성물
JP2013227256A (ja) 血管内皮機能改善剤
KR20100060949A (ko) 신경세포 보호용 조성물
CN103298465B (zh) 升麻消旋体a和其相关化合物用于治疗炎症和调节免疫应答的用途
WO1999029647A1 (en) Apoptosis inducer
Ouedraogo et al. LC-MS profile and in vivo oral acute toxicity, antihypertensive and vascular endothelium protective effects of phenolic compounds of the ethyl acetate fraction of leafy stems of Flemingia faginea Guill. & Perr. in L-NAME induced hypertensive mice
CN108379455A (zh) 一种降尿酸组合物
Dracheva et al. Extracellular vesicles secreted by adipose tissue during obesity and type 2 diabetes mellitus influence cholesterol metabolism gene expression in human macrophages
TWI645083B (zh) 篩選抑制發炎反應及血管保護活性物質之方法
US9321795B2 (en) Use of hydroxycinnamaldehyde glycoside derivatives for treating glomerulonephritis
US20100221368A1 (en) Methods for Inhibiting Cytokines
AU2002218747A1 (en) Use of dammarane-type tritepenoid saporins
WO2011106867A1 (en) Tunicate extracts and uses thereof in anti-allergy applications
HK1186097A (en) Uses of cimiracemate a and related compounds for treating inflammation and modulating immune responses

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201130

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201130

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211116

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20220201

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20220209

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220216

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220513

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220817

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220906

R150 Certificate of patent or registration of utility model

Ref document number: 7138639

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250